Edwards Lifesciences Corp Stock Total Debt
EW Stock | USD 95.15 1.73 1.85% |
Edwards Lifesciences Corp fundamentals help investors to digest information that contributes to Edwards Lifesciences' financial success or failures. It also enables traders to predict the movement of Edwards Stock. The fundamental analysis module provides a way to measure Edwards Lifesciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Edwards Lifesciences stock.
Total Debt To Capitalization is likely to drop to 0.09 in 2024. Edwards | Total Debt |
Edwards Total Debt Analysis
Edwards Lifesciences' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
More About Total Debt | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 3.9M | 311M | 15.2M | 14.4M | Total Assets | 8.5B | 8.3B | 9.4B | 9.8B |
Total Debt | = | Bonds | + | Notes |
Current Edwards Lifesciences Total Debt | 694.9 M |
Most of Edwards Lifesciences' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Edwards Lifesciences Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Edwards Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Edwards Lifesciences is extremely important. It helps to project a fair market value of Edwards Stock properly, considering its historical fundamentals such as Total Debt. Since Edwards Lifesciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Edwards Lifesciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Edwards Lifesciences' interrelated accounts and indicators.
Click cells to compare fundamentals
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition |
Edwards Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, Edwards Lifesciences Corp has a Total Debt of 694.9 M. This is 74.74% lower than that of the Health Care Equipment & Supplies sector and 60.22% lower than that of the Health Care industry. The total debt for all United States stocks is 86.93% higher than that of the company.
Edwards Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Edwards Lifesciences' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Edwards Lifesciences could also be used in its relative valuation, which is a method of valuing Edwards Lifesciences by comparing valuation metrics of similar companies.Edwards Lifesciences is currently under evaluation in total debt category among related companies.
Edwards Lifesciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Edwards Lifesciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Edwards Lifesciences' managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Edwards Lifesciences Institutional Holders
Institutional Holdings refers to the ownership stake in Edwards Lifesciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Edwards Lifesciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Edwards Lifesciences' value.Shares | Fmr Inc | 2023-12-31 | 7.5 M | Fisher Asset Management, Llc | 2023-12-31 | 7.1 M | Goldman Sachs Group Inc | 2023-12-31 | 7 M | Amundi | 2023-12-31 | 6.2 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 6.1 M | Sands Capital Management, Llc | 2023-12-31 | 6.1 M | Northern Trust Corp | 2023-12-31 | 6 M | Hhg Plc | 2023-12-31 | 5.6 M | Legal & General Group Plc | 2023-12-31 | 5.5 M | Vanguard Group Inc | 2023-12-31 | 52.4 M | Blackrock Inc | 2023-12-31 | 52.2 M |
Edwards Fundamentals
Return On Equity | 0.22 | ||||
Return On Asset | 0.12 | ||||
Profit Margin | 0.23 % | ||||
Operating Margin | 0.39 % | ||||
Current Valuation | 56.26 B | ||||
Shares Outstanding | 601.3 M | ||||
Shares Owned By Insiders | 0.84 % | ||||
Shares Owned By Institutions | 83.68 % | ||||
Number Of Shares Shorted | 8.44 M | ||||
Price To Earning | 32.77 X | ||||
Price To Book | 8.60 X | ||||
Price To Sales | 9.53 X | ||||
Revenue | 6 B | ||||
Gross Profit | 4.3 B | ||||
EBITDA | 1.53 B | ||||
Net Income | 1.4 B | ||||
Cash And Equivalents | 769 M | ||||
Cash Per Share | 2.81 X | ||||
Total Debt | 694.9 M | ||||
Debt To Equity | 0.11 % | ||||
Current Ratio | 3.83 X | ||||
Book Value Per Share | 11.06 X | ||||
Cash Flow From Operations | 895.8 M | ||||
Short Ratio | 1.77 X | ||||
Earnings Per Share | 2.30 X | ||||
Price To Earnings To Growth | 5.47 X | ||||
Target Price | 92.36 | ||||
Number Of Employees | 19.8 K | ||||
Beta | 1.05 | ||||
Market Capitalization | 57.21 B | ||||
Total Asset | 9.36 B | ||||
Retained Earnings | 8.99 B | ||||
Working Capital | 2.84 B | ||||
Current Asset | 2.05 B | ||||
Current Liabilities | 476.2 M | ||||
Z Score | 52.29 | ||||
Net Asset | 9.36 B |
About Edwards Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Edwards Lifesciences Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Edwards Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Edwards Lifesciences Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Total Debt To Capitalization | 0.09 | 0.09 |
Edwards Lifesciences Investors Sentiment
The influence of Edwards Lifesciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Edwards. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Edwards Lifesciences' public news can be used to forecast risks associated with an investment in Edwards. The trend in average sentiment can be used to explain how an investor holding Edwards can time the market purely based on public headlines and social activities around Edwards Lifesciences Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Edwards Lifesciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Edwards Lifesciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Edwards Lifesciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Edwards Lifesciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Edwards Lifesciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Edwards Lifesciences' short interest history, or implied volatility extrapolated from Edwards Lifesciences options trading.
Pair Trading with Edwards Lifesciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.Moving against Edwards Stock
0.86 | SSY | SunLink Health Systems | PairCorr |
0.69 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
0.65 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
0.65 | FIGS | Figs Inc Financial Report 2nd of May 2024 | PairCorr |
0.62 | NEOG | Neogen Report 4th of April 2024 | PairCorr |
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Edwards Lifesciences Piotroski F Score and Edwards Lifesciences Altman Z Score analysis. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Transaction History View history of all your transactions and understand their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.3 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.